Taylor Hoffman Wealth Management Abb Vie Inc. Transaction History

Taylor Hoffman Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $156,957 - $184,216	-1,827 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $134,046 - $179,374	1,827 New	1,827 $179,000
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $79,206 - $120,086	-1,228 Closed	0 $0
Q4 2018 Jul 11, 2019	SELL	$77.85 - $96.01 $31,139 - $38,404	-400 Reduced 24.57%	1,228 $113,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $124,309 - $136,315	1,388 Added 578.33%	1,628 $157,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $21,494 - $23,570	240	240 $23,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Taylor Hoffman Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Taylor Hoffman Wealth Management with notifications on news.